The effect of fluid injection on lesion size during radiofrequency treatment.
OBJECTIVE
Previous ex vivo studies on monopolar radiofrequency have not incorporated the preinjection of fluid before radiofrequency ablation into study design. The objective of this study was to investigate the effects of the preinjection of small volumes of different fluids on lesion dimensions.


METHODS
Monopolar radiofrequency lesioning with temperature control at 80 degrees C for 90 secs in ex vivo chicken samples with 100-mm, 18-gauge cannulas and 10-mm active tips was performed with 1 reference group without fluid injection and 4 comparison groups with 0.5 mL of volumes of sterile water, 0.9% sodium chloride, 1% lidocaine, or 6% hydroxyethylstarch injected before ablation. A fifth comparison group of 3 mL of 0.9% sodium chloride was used to evaluate the influence of increased volume.Lesions were measured in horizontal diameter, vertical diameter, maximal effective radius, and distal radius from the tip of electrode.


RESULTS
Injecting fluid before lesioning led to larger lesion size parameters(P < 0.01) for the 5 comparison groups relative to control; 6% hydroxyethyl starch produced the largest size and shape parameters,which were statistically significant (P < or = 0.017) for all measurements compared with control and water.


CONCLUSIONS
The influence of the composition of the pre-injected fluid should be considered for monopolar radiofrequency ablation. This ex vivo study revealed a simple method to increase monopolar radiofrequency lesion size. Future research is needed to determine the degree of influence of the composition of the fluid on thermal and electrical conductivity.
Provenzano
David A
DA
Institute for Pain Diagnostics and Care, Ohio Valley General Hospital, McKees Rocks, PA 15136, USA. davidprovenzano@hotmail.com
Lassila
Holly C
HC
Somers
David
D
D000698:Analgesia / Q000379:methods*; D000818:Animals; D017115:Catheter Ablation; D002645:Chickens; D003714:Denervation; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage*; D007267:Injections; D008012:Lidocaine / Q000008:administration & dosage*; D008460:Meat; D018482:Muscle, Skeletal / Q000473:pathology / Q000601:surgery*; D012965:Sodium Chloride / Q000008:administration & dosage*; D014867:Water / Q000008:administration & dosage*
D006895:Hydroxyethyl Starch Derivatives; D014867:Water; D012965:Sodium Chloride; D008012:Lidocaine